These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33471127)

  • 1. Patients and clinicians define symptom levels and meaningful change for PROMIS pain interference and fatigue in RA using bookmarking.
    Bingham CO; Butanis AL; Orbai AM; Jones M; Ruffing V; Lyddiatt A; Schrandt MS; Bykerk VP; Cook KF; Bartlett SJ
    Rheumatology (Oxford); 2021 Sep; 60(9):4306-4314. PubMed ID: 33471127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of Functional Assessment of Chronic Illness Therapy-Fatigue to Patient-Reported Outcomes Measurement Information System Fatigue Scores in Two Phase III Baricitinib Rheumatoid Arthritis Trials.
    Bingham CO; Bartlett SJ; Kannowski C; Sun L; DeLozier AM; Cella D
    Arthritis Care Res (Hoboken); 2021 Apr; 73(4):481-488. PubMed ID: 31961494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying Minimal and Meaningful Change in a Patient-Reported Outcomes Measurement Information System for Rheumatoid Arthritis: Use of Multiple Methods and Perspectives.
    Bartlett SJ; Gutierrez AK; Andersen KM; Bykerk VP; Curtis JR; Haque UJ; Orbai AM; Jones MR; Bingham CO
    Arthritis Care Res (Hoboken); 2022 Apr; 74(4):588-597. PubMed ID: 33166066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meaningful Change Thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue and Pain Interference Scores in Patients With Rheumatoid Arthritis.
    Beaumont JL; Davis ES; Curtis JR; Cella D; Yun H
    J Rheumatol; 2021 Aug; 48(8):1239-1242. PubMed ID: 33722955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardizing and personalizing the treat to target (T2T) approach for rheumatoid arthritis using the Patient-Reported Outcomes Measurement Information System (PROMIS): baseline findings on patient-centered treatment priorities.
    Bacalao EJ; Greene GJ; Beaumont JL; Eisenstein A; Muftic A; Mandelin AM; Cella D; Ruderman EM
    Clin Rheumatol; 2017 Aug; 36(8):1729-1736. PubMed ID: 28653263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and Validity of Selected PROMIS Measures in People with Rheumatoid Arthritis.
    Bartlett SJ; Orbai AM; Duncan T; DeLeon E; Ruffing V; Clegg-Smith K; Bingham CO
    PLoS One; 2015; 10(9):e0138543. PubMed ID: 26379233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment.
    Cella D; Choi S; Garcia S; Cook KF; Rosenbloom S; Lai JS; Tatum DS; Gershon R
    Qual Life Res; 2014 Dec; 23(10):2651-61. PubMed ID: 24938431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing clinical meaning and defining important differences for Patient-Reported Outcomes Measurement Information System (PROMIS
    Morgan EM; Mara CA; Huang B; Barnett K; Carle AC; Farrell JE; Cook KF
    Qual Life Res; 2017 Mar; 26(3):565-586. PubMed ID: 27913986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meaningful score changes for SF-36v2, FACIT-fatigue, and RASIQ in rheumatoid arthritis.
    Rendas-Baum R; Lin X; Kosinski M; Bjorner JB; Bracher MG; Chen WH
    J Patient Rep Outcomes; 2024 Jan; 8(1):9. PubMed ID: 38252223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing clinically-relevant terms and severity thresholds for Patient-Reported Outcomes Measurement Information System
    Rothrock NE; Cook KF; O'Connor M; Cella D; Smith AW; Yount SE
    Qual Life Res; 2019 Dec; 28(12):3355-3362. PubMed ID: 31410640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying clinically meaningful severity categories for PROMIS pediatric measures of anxiety, mobility, fatigue, and depressive symptoms in juvenile idiopathic arthritis and childhood-onset systemic lupus erythematosus.
    Mann CM; Schanberg LE; Wang M; von Scheven E; Lucas N; Hernandez A; Ringold S; Reeve BB
    Qual Life Res; 2020 Sep; 29(9):2573-2584. PubMed ID: 32410143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using bookmarking methods with orthopedic clinicians and patients with fractures produces score interpretation labels for patient-reported outcome measures.
    Rothrock NE; Wilson SA; Heng M; Hodor A; Joeris A; Kaat AJ; McKelvey K; Schalet BD; Vrahas M
    Qual Life Res; 2023 Oct; 32(10):2779-2787. PubMed ID: 37227662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Rheumatoid Arthritis Disease Activity With Patient-Reported Outcomes Measurement Information System Measures Using Digital Technology.
    Yun H; Nowell WB; Curtis D; H Willig J; Yang S; Auriemma M; Chen L; Filby C; Curtis JR
    Arthritis Care Res (Hoboken); 2020 Apr; 72(4):553-560. PubMed ID: 30927515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do Patient Sociodemographic Factors Impact the PROMIS Scores Meeting the Patient-Acceptable Symptom State at the Initial Point of Care in Orthopaedic Foot and Ankle Patients?
    Bernstein DN; Mayo K; Baumhauer JF; Dasilva C; Fear K; Houck JR
    Clin Orthop Relat Res; 2019 Nov; 477(11):2555-2565. PubMed ID: 31261259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY.
    Strand V; Tundia N; Wells A; Buch MH; Radominski SC; Camp HS; Friedman A; Suboticki JL; Dunlap K; Goldschmidt D; Bergman M
    Rheumatology (Oxford); 2021 Jul; 60(7):3209-3221. PubMed ID: 33313898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating PROMIS Measures in a Treat-to-Target Approach to Standardize Patient-Centered Treatment of Rheumatoid Arthritis.
    Greene GJ; Beaumont JL; Bacalao EJ; Muftic A; Kaiser K; Eisenstein AR; Mandelin AM; Cella D; Ruderman EM
    J Rheumatol; 2023 Aug; 50(8):1002-1008. PubMed ID: 37127317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group.
    Saygin D; DiRenzo D; Raaphorst J; de Groot I; Bingham CO; Lundberg IE; Regardt M; Sarver C; de Visser M; Maxwell LJ; Beaton D; Kim JY; Needham M; Alexanderson H; Christopher-Stine L; Mecoli CA; Park JK;
    Semin Arthritis Rheum; 2024 Feb; 64():152339. PubMed ID: 38141522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds.
    Strand V; Kosinski M; Gnanasakthy A; Mallya U; Mpofu S
    Health Qual Life Outcomes; 2014 Mar; 12():31. PubMed ID: 24597620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Are the MCIDs for PROMIS, NDI, and ODI Instruments Among Patients With Spinal Conditions?
    Hung M; Saltzman CL; Kendall R; Bounsanga J; Voss MW; Lawrence B; Spiker R; Brodke D
    Clin Orthop Relat Res; 2018 Oct; 476(10):2027-2036. PubMed ID: 30179950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROMIS 4-item measures and numeric rating scales efficiently assess SPADE symptoms compared with legacy measures.
    Kroenke K; Stump TE; Kean J; Talib TL; Haggstrom DA; Monahan PO
    J Clin Epidemiol; 2019 Nov; 115():116-124. PubMed ID: 31330252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.